Compare ICCM & JF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ICCM | JF |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | Israel | China |
| Employees | N/A | 30 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 19.1M |
| IPO Year | 2013 | N/A |
| Metric | ICCM | JF |
|---|---|---|
| Price | $3.35 | $0.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 8.8M | 5.7K |
| Earning Date | 05-27-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $139.51 | N/A |
| Revenue Next Year | $75.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.86 |
| 52 Week High | $9.54 | $1.19 |
| Indicator | ICCM | JF |
|---|---|---|
| Relative Strength Index (RSI) | 45.58 | 35.09 |
| Support Level | $0.48 | N/A |
| Resistance Level | $5.69 | $1.02 |
| Average True Range (ATR) | 0.34 | 0.06 |
| MACD | -0.28 | -0.01 |
| Stochastic Oscillator | 4.48 | 9.85 |
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
J and Friends Holdings Ltd providing merchant digitalization and commerce-enablement solutions to small and medium enterprises (SME). Its solutions feature critical functionality that SMEs need to engage with consumers, manage their operations, accept payments, and grow their business. Such solutions empower single- and multi-location retailers, restaurants, and other SMEs to compete successfully in an omni-channel market environment by engaging with consumers across online, mobile, and physical channels. The group conducts all of its current operations in Australia and generates revenues from continuing operations are derived from within Australia.